243 filings
Page 7 of 13
8-K
pyujwfnck vo6k4vplmm
26 Jul 18
Entry into a Material Definitive Agreement
5:29pm
8-K
8j7rzvi
10 Jul 18
Other Events
12:57pm
8-K
s07xxpvi6 g4ze
29 Jun 18
CytoSorbents Added to the Russell 2000 and Russell 3000 Indexes
12:51pm
8-K
qyz5hg biffvhjc
14 Jun 18
Other Events
12:00am
8-K
c9zy11b07xueff
8 Jun 18
CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference
1:22pm
8-K
r2zgf a30pq0id51c
7 Jun 18
Submission of Matters to a Vote of Security Holders
9:44pm
8-K
5zb1rnj
24 May 18
Other Events
12:00am
8-K
timavjovpvl i2hmv
9 May 18
CytoSorbents Reports Strong First Quarter 2018 Financial Results
12:00am
8-K
as3 zps2z
4 Apr 18
Extends the interest only period of the existing $10M debt by 18 months and adds the option for an additional $5M in debt
12:00am
8-K
ft1ik1on
20 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
rgc3qklelw8 wwm
14 Mar 18
Full Year 2017 and Q4 2017 Earnings and Operating Results Conference Call
12:00am
8-K
0vt 6bhjo6t9zlw6v0z
5 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
th2c3 152tkq
9 Jan 18
Full Year 2017 Results and Issues Stockholder Letter
12:00am
8-K
6izjbb0n4e
26 Dec 17
CytoSorbents Achieves Key Milestone with FDA Approval of the U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application
12:00am
8-K
0b2xiybl
13 Nov 17
CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
12:00am
8-K
zuzd6uepyq5 ai2u
9 Aug 17
CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017
12:00am
8-K
bgep2
6 Jul 17
CytoSorbents Receives Additional $5 Million in Non-Dilutive Debt Financing from Bridge Bank
12:00am
8-K
elj2 otozfuqwic
7 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ifsht9ez74agsibme
30 May 17
Dr. Eric R. Mortensen, M.D., Ph.D., Clinical Trial Veteran, Joins CytoSorbents as Chief Medical Officer
12:00am
8-K
h2poxock
12 May 17
CytoSorbents Reports First Quarter 2017 Financial Results
12:00am